Developing revolutionary fusion technology in the U.S. and abroad.
Our 105-acre headquarters includes Chrysalis, Cassiopeia, and Building One. Chrysalis, under construction, will supply molybdenum-99 for medical imaging. Cassiopeia, our lutetium-177 facility, can meet rising demand for cancer therapies. Building One supports ongoing technology development, including FLARE.
Our Fitchburg campus, Heliopolis, houses our Systems and Manufacturing division, where fusion systems are designed, built, and tested. The same site includes the Phoenix Imaging Center, which provides neutron radiography and testing for aerospace, defense, and advanced manufacturing.
The North Billerica SPECT facility has manufactured TechneLite® (Technetium Tc 99m Generator) for 55 years, serving hospitals and imaging centers across North America. The site produces SPECT imaging agents that support millions of diagnostic procedures annually for cardiac, pulmonary, thyroid, and other applications.
SHINE Europe is developing the company’s first medical-isotope production facility outside the U.S. The planned site will follow the Chrysalis design to provide molybdenum-99 and lutetium-177 for European clinics and research partners, helping strengthen resilience in the global isotope supply chain.
